» Articles » PMID: 7684168

Prostatic Intra-epithelial Neoplasia: Expression and Location of Proliferating Cell Nuclear Antigen in Epithelial, Endothelial and Stromal Nuclei

Overview
Date 1993 Jan 1
PMID 7684168
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The expression and location of proliferating cell nuclear antigen (PCNA) immunostaining in epithelial, endothelial and stromal nuclei were assessed in prostatic intra-epithelial neoplasia (PIN). It was then compared with patterns in benign lesions and in invasive adenocarcinomas of the prostate. The PCNA-positive nuclei showed homogeneous or granular types of staining, or a mixture of both, and a gradation in the intensity of staining. Nuclei with granular and mixed patterns appeared lighter brown than those with a homogeneous pattern, which are darker and more often noted in PIN and invasive adenocarcinomas than in benign lesions. For epithelial PCNA-stained nuclei, the proportions in the two grades of PIN were greater than in benign prostatic hyperplasia (mean 3.16%, SE 0.31%) and prostatic atrophic ducts and acini (mean 0.56%, SE 0.09%), the values decreasing from the nuclei in the basal position towards those in the luminal layer. In grade 1, the category mean values were 9.51% (SE 1.14%) in the basal, 7.02% (SE 1.27%) in the intermediate and 6.02% (SE 0.90%) in the luminal position. In grade 2, the category mean values were 13.81% (SE 1.42%) in the basal position, 10.99% (SE 1.17%) in the intermediate and 7.91% (SE 1.43%) in the luminal position. In small and large acinar adenocarcinomas, the proportions of positive nuclei were 8.66% (SE 0.30%) and 9.06% (SE 0.30%), respectively. The category mean values in the cribriform adenocarcinomas were 14.40% (SE 0.61%) in the basal position, 11.84% (SE 1.30%) in the intermediate and 9.26% (SE 0.66%) in the luminal position. As in PIN, the proportions of immunostained nuclei in the adenocarcinoma with cribriform pattern decreased from the basal towards the luminal layer. In the solid/trabecular adenocarcinomas, the category mean value in the cell layer adjacent to the stroma was 17.60% (SE 2.92%), whereas in the other cell layers it was lower than that in the cells adjacent the stroma (mean 13.88%, SE 1.71%). For capillary endothelial and stromal cells, the percentages of PCNA-stained nuclei were much lower than those in the epithelial component. The lowest mean values were obtained in benign lesions, whereas the highest were in invasive adenocarcinomas, the percentages in PIN being intermediate.

Citing Articles

Molecular pathogenesis of human prostate basal cell hyperplasia.

Henry G, Malewska A, Mauck R, Gahan J, Hutchinson R, Torrealba J Prostate. 2017; 77(13):1344-1355.

PMID: 28795417 PMC: 5580247. DOI: 10.1002/pros.23394.


DNA replication regulation protein Mcm7 as a marker of proliferation in prostate cancer.

Padmanabhan V, Callas P, Philips G, Trainer T, Beatty B J Clin Pathol. 2004; 57(10):1057-62.

PMID: 15452160 PMC: 1770448. DOI: 10.1136/jcp.2004.016436.


Relation of Bcl-2 expression to androgen receptor, p21WAF1/CIP1, and cyclin D1 status in prostate cancer.

Kolar Z, Murray P, Scott K, Harrison A, Vojtesek B, Dusek J Mol Pathol. 2000; 53(1):15-8.

PMID: 10884916 PMC: 1186896. DOI: 10.1136/mp.53.1.15.


Precursor lesions for prostate cancer.

Feneley M, Busch C J R Soc Med. 1998; 90(10):533-9.

PMID: 9488009 PMC: 1296593. DOI: 10.1177/014107689709001003.


Ki-67 expression in early prostate cancer and associated pathological lesions.

Feneley M, Young M, Chinyama C, Kirby R, Parkinson M J Clin Pathol. 1996; 49(9):741-8.

PMID: 9038759 PMC: 500724. DOI: 10.1136/jcp.49.9.741.


References
1.
JEWETT H . The present status of radical prostatectomy for stages A and B prostatic cancer. Urol Clin North Am. 1975; 2(1):105-24. View

2.
McNeal J . Normal histology of the prostate. Am J Surg Pathol. 1988; 12(8):619-33. DOI: 10.1097/00000478-198808000-00003. View

3.
Montironi R, Galluzzi C, Diamanti L, Taborro R, Scarpelli M, Pisani E . Prostatic intra-epithelial neoplasia. Qualitative and quantitative analyses of the blood capillary architecture on thin tissue sections. Pathol Res Pract. 1993; 189(5):542-8. View

4.
Linden M, Torres F, Kubus J, Zarbo R . Clinical application of morphologic and immunocytochemical assessments of cell proliferation. Am J Clin Pathol. 1992; 97(5 Suppl 1):S4-13. View

5.
Takahashi H, Strutton G, Parsons P . Determination of proliferating fractions in malignant melanomas by anti-PCNA/cyclin monoclonal antibody. Histopathology. 1991; 18(3):221-7. DOI: 10.1111/j.1365-2559.1991.tb00829.x. View